Last week President Trump made a number of announcements related to health insurance policy. First, he signed an executive order that seeks to increase competition by facilitating access to association health plans, short-term limited duration insurance products, and health reimbursement arrangements. Nothing is changing immediately; rather, the president has directed several government agencies to draft...
Author: Mark Newman
On September 14, members of the Endocrine Society joined over 400 research advocates in Washington, D.C., to visit members of Congress and call for increased funding for biomedical research as part of the Rally for Medical Research. Endocrine Society members Heather Patisaul, PhD, Benson Tokunbo Akingbemi, PhD, DVM, T. Rajendra Kumar, PhD, MSC, and Lindsey...
The Society always invites your questions, comments, and solutions for improvement. This year especially, we proactively sought input into our Fourth Strategic Plan (SP4). We surveyed our membership, held focus group meetings (targeting international members and past leaders), and interviewed “lapsed” members and outside stakeholders (e.g. insurers, deans, pharma). The resulting input fed into the...Endocrine Society Concerned Over Scaling Back ACA Contraception Coverage
The Endocrine Society expressed concerns Friday with the presidential administration’s new rules that would scale back the Affordable Care Act’s contraception coverage mandate. The Society called for future health reform efforts to include continued access to no-cost hormonal contraception in a position statement issued last month. The rules, which took effect Friday, allow companies to...
According to an Endocrine Society Scientific Statement, patients need to be counseled about the risks of custom-compounded bioidentical hormones. The preferred treatments should have been vetted by the U.S. Food and Drug Administration, not Oprah. Physicians may need to take time to explain to patients the potential risks of using “bioidentical hormone” formulations made by...
The Endocrine Society welcomed the European Parliament vote Wednesday objecting to proposed criteria that would have failed to identify endocrine-disrupting chemicals (EDCs) currently causing harm to public health. In the months leading up to the vote, the Society repeatedly expressed concerns the rejected criteria would not ensure a high level of health and environmental protection....
Endocrine Society Announces Early Investigators Award Winners
On October 3, the Endocrine Society announced 22 new recipients for its Early Investigators Awards. The Early Investigators Awards provide monetary support to assist in the development of early career investigators and recognition of their accomplishments in areas of general endocrinology. Recipients will receive a monetary award, one-year complimentary membership to the Society, one-year complimentary...
Endocrine Society’s Diabetes Briefing on Capitol Hill “Goes to the Dogs”
On September 14, the Endocrine Society hosted a briefing on Capitol Hill titled “Diabetes in America: Research Accomplishments and Clinical Challenges,” sponsored by Rep. Buddy Carter (R-GA). The briefing featured presentations from Judith Fradkin, MD, of the National Institutes of Health, who shared accomplishments in diabetes research; Shivani Agarwal, MD, MPH, of the University of...